Drugs / Gabexate Mesilate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02710266 | Feb 2012 → Feb 2017 | liver disorder | Yonsei University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gabexate Mesilate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02710266 ↗ |
| Action | Inhibit | “inhibition of acute inflammatory cytokine reaction” NCT02710266 ↗ |
| Modality | Other / unclassified | “synthetic protease inhibitor” NCT02710266 ↗ |